These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32681366)

  • 21. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis.
    Bolland MJ; Grey A; Avenell A
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):847-858. PubMed ID: 30293909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
    Saag KG; Pannacciulli N; Geusens P; Adachi JD; Messina OD; Morales-Torres J; Emkey R; Butler PW; Yin X; Lems WF
    Arthritis Rheumatol; 2019 Jul; 71(7):1174-1184. PubMed ID: 30816640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitriol treatment in patients with low vitamin D levels.
    Tanakol R; Gül N; Üzüm AK; Aral F
    Arch Osteoporos; 2018 Oct; 13(1):114. PubMed ID: 30353299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials.
    Hu L; Ji J; Li D; Meng J; Yu B
    J Orthop Surg Res; 2021 Oct; 16(1):592. PubMed ID: 34649591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation.
    Shams-White MM; Chung M; Du M; Fu Z; Insogna KL; Karlsen MC; LeBoff MS; Shapses SA; Sackey J; Wallace TC; Weaver CM
    Am J Clin Nutr; 2017 Jun; 105(6):1528-1543. PubMed ID: 28404575
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.
    Jayasena A; Atapattu N; Lekamwasam S
    Int J Rheum Dis; 2015 Mar; 18(3):287-93. PubMed ID: 25923606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive high-intensity resistance training and bone mineral density changes among premenopausal women: evidence of discordant site-specific skeletal effects.
    Martyn-St James M; Carroll S
    Sports Med; 2006; 36(8):683-704. PubMed ID: 16869710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
    Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
    Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate.
    Sambrook PN; Roux C; Devogelaer JP; Saag K; Lau CS; Reginster JY; Bucci-Rechtweg C; Su G; Reid DM
    Bone; 2012 Jan; 50(1):289-95. PubMed ID: 22061864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Oliveira LC; Oliveira RG; Pires-Oliveira DA
    Osteoporos Int; 2016 Oct; 27(10):2913-33. PubMed ID: 27145947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis.
    Sanderson J; Martyn-St James M; Stevens J; Goka E; Wong R; Campbell F; Selby P; Gittoes N; Davis S
    Bone; 2016 Aug; 89():52-58. PubMed ID: 27262775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD; Farahmand P; Schacht E; Rozehnal A
    Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN; Hammami MM; Bakheet SM; Khan BA
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
    Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
    Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.